RhumbLine Advisers’s Cellectis CLLS Stock Holding History

RhumbLine Advisers’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$43K	Sell	14,328 -757	-5%	-$2.69K	﹤0.01%	3706
2026 Q1	$47.8K	Buy	15,085 +1,742	+13%	+$6.68K	﹤0.01%	3596
2025 Q4	$64.6K	Buy	13,343 +11,888	+817%	+$49.7K	﹤0.01%	3585
2025 Q3	$4.15K	Sell	1,455 -450	-24%	-$1.17K	﹤0.01%	3927
2025 Q2	$2.88K	Sell	1,905 -210	-10%	-$303	﹤0.01%	3964
2025 Q1	$2.62K	Hold	2,115	–	–	﹤0.01%	3964
2024 Q4	$3.81K	Sell	2,115 -1,740	-45%	-$3.25K	﹤0.01%	3985
2024 Q3	$8.25K	Hold	3,855	–	–	﹤0.01%	3915
2024 Q2	$7.21K	Hold	3,855	–	–	﹤0.01%	4024
2024 Q1	$10.2K	Hold	3,855	–	–	﹤0.01%	3867
2023 Q4	$11.9K	Buy	3,855 +885	+30%	+$2.1K	﹤0.01%	3838
2023 Q3	$4.69K	Hold	2,970	–	–	﹤0.01%	3989
2023 Q2	$5.85K	Buy	+2,970	New	+$5.69K	﹤0.01%	4058

Other funds holding CLLS

BGI

B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

RhumbLine Advisers's CLLS Position: Q2 2026 in Review

RhumbLine Advisers reduced its Cellectis (CLLS) stake by 5% in Q2 2026, selling an estimated $2.69K and leaving 14,328 shares worth $43K. The position accounts for ﹤0.01% of the portfolio, ranked #3706.

RhumbLine Advisers first reported a position in CLLS in Q2 2023 and has held it in 13 quarters since. The position peaked at $64.6K in Q4 2025. 27 funds tracked by Wall St. Rank hold CLLS as of Q2 2026.

RhumbLine Advisers held 14,328 shares of Cellectis worth $43K as of Q2 2026.
RhumbLine Advisers sold 757 Cellectis shares in Q2 2026, an estimated $2.69K.
Cellectis made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #3706 holding.
RhumbLine Advisers first reported a position in Cellectis in Q2 2023 and has held it in 13 quarters since.
RhumbLine Advisers's Cellectis position peaked at $64.6K in Q4 2025.
27 funds tracked by Wall St. Rank held Cellectis as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.